What is Shandong Xinhua Pharmaceutical Company Limited's (000756.SZ) StockRank?

MoatMap's StockRank for Shandong Xinhua Pharmaceutical Company Limited (000756.SZ) is 62/100, with a Hold signal. This is a composite score combining Quality (55), Value (51), and Momentum (44) factor ranks across MoatMap's 19,000+ stock universe.

Does Shandong Xinhua Pharmaceutical Company Limited have an economic moat?

Shandong Xinhua Pharmaceutical Company Limited (000756.SZ) has a Quality factor score of 55/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Shandong Xinhua Pharmaceutical Company Limited a buy, hold, or sell?

MoatMap's current signal for Shandong Xinhua Pharmaceutical Company Limited (000756.SZ) is Hold, based on a StockRank of 62/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Shandong Xinhua Pharmaceutical Company Limited in?

Shandong Xinhua Pharmaceutical Company Limited (000756.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

000756.SZ

HOLDREMOVE

Shandong Xinhua Pharmaceutical Company Limited · Healthcare · China · $1.4B · Avg Vol: $10M/d

StockRank

P/E (TTM)

31.9x

ROE

5.0%

D/E

0.3x

Dividend %

1.2%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Shandong Xinhua Pharmaceutical is a domestic Chinese API manufacturer that does not meet our quality criteria or align with the global CDMO pricing power theme.

COMPANY DESCRIPTION

Shandong Xinhua Pharmaceutical Company Limited is a global leader in the manufacture of active pharmaceutical ingredients (APIs) and finished dosages, renowned as the world's largest production base for ibuprofen. The company's massive economies of scale, vertically integrated production, and stringent international quality certifications form a powerful competitive moat. It serves as a critical supplier to major global pharmaceutical brands across Europe, the Americas, and Asia.

FINANCIAL SUMMARY

Year	2022	2023	2024	2025	CAGR
Revenue	1.1B	1.2B	1.3B	1.3B	5.3%
EPS	0.09	0.11	0.10	0.06	-12.2%
Shares	670M	675M	682M	690M	+3.0%
Debt	205M	201M	246M	219M	2.3%
Equity	610M	673M	738M	770M	8.1%
Op CF	112M	39M	54M	79M	-11.0%
Inv CF	-34M	-45M	-31M	-15M	—
Fin CF	-19M	-29M	27M	-43M	—

PRICE (1M)-13.0%

SMA 50SMA 200

$1.82

RSI (14)

29.9

52W High

$2.76

From 52W High

0.7%

SCORE BREAKDOWN

Quality

ROIC

6.3%61.3

ROE

5.0%56.3

GP/Assets

17.2%40.3

Op. Margin

5.5%56.0

FCF/Assets

5.5%72.3

Piotroski

—83.5

Int. Cover

9.5x63.5

D/E Ratio

0.25x46.9

Current Ratio

1.76x31.9

Value

P/E (TTM)

31.9x34.6

EV/EBITDA

9.5x43.5

P/FCF

126.3x63.1

P/B

1.6x63.3

P/S

1.0x84.1

Div Yield

1.2%34.0

Momentum

52W High %

66%49.9

RS 6M

-36%33.5

SMA 50/200

0.90x34.1

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—82.7

Q Growth

-25%21.0

FUNDAMENTALS

Market Cap

$1.4B

P/E (Forward)

12.7x

Gross Margin

18.0%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 000756.SZ are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
000756.SZ	Shandong Xinhua Pharmaceutical Company Limited(you)	$1.4B	62	HOLD
601089.SS	Beijing Foyou Pharma CO.,LTD	$1.3B	61	HOLD
300725.SZ	PharmaBlock Sciences (Nanjing), Inc.	$1.2B	60	HOLD
603456.SS	Zhejiang Jiuzhou Pharmaceutical Co., Ltd	$1.7B	62	HOLD
2186.HK	Luye Pharma Group Ltd.	$1.1B	61	HOLD
002550.SZ	Changzhou Qianhong Biopharma CO.,LTD	$1.2B	66	BUY
600557.SS	Jiangsu Kanion Pharmaceutical Co.,Ltd.	$1.1B	65	HOLD
600195.SS	China Animal Husbandry Industry Co., Ltd.	$996M	64	HOLD
000597.SZ	Northeast Pharmaceutical Group Co., Ltd.	$983M	64	HOLD
002020.SZ	Zhejiang Jingxin Pharmaceutical Co., Ltd.	$1.7B	57	HOLD

Peer medians: ROE 4.7% · P/E 27.8x · Gross margin 53.2%

Shandong Xinhua Pharmaceutical Company Limited (000756.SZ) — Stock Score Summary

Shandong Xinhua Pharmaceutical Company Limited (000756.SZ) has a MoatMap StockRank of 62/100 based on Quality (55/100), Value (51/100), and Momentum (44/100) factor scores. The current signal is HOLD. Shandong Xinhua Pharmaceutical is a domestic Chinese API manufacturer that does not meet our quality criteria or align with the global CDMO pricing power theme.

Key Financial Metrics

Price	$1.82
Market Cap	$1.4B
P/E (TTM)	31.95
P/E (Forward)	12.71
Price/Book	1.62
Return on Equity	5.0%
Return on Invested Capital	6.3%
Debt/Equity	25.39
Gross Margin	18.0%
Operating Margin	5.5%
Revenue Growth	-0.3%
Dividend Yield	1.2%
Free Cash Flow	$11M

Shandong Xinhua Pharmaceutical Company Limited operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Shandong Xinhua Pharmaceutical Company Limited’s (000756.SZ) StockRank?: MoatMap’s StockRank for Shandong Xinhua Pharmaceutical Company Limited (000756.SZ) is 62/100, with a Hold signal. It is a composite of Quality (55), Value (51), and Momentum (44) factor ranks across MoatMap’s 19,000+ stock universe.
Does Shandong Xinhua Pharmaceutical Company Limited have an economic moat?: Shandong Xinhua Pharmaceutical Company Limited (000756.SZ) has a Quality factor score of 55/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Shandong Xinhua Pharmaceutical Company Limited a buy, hold, or sell?: MoatMap’s current signal for Shandong Xinhua Pharmaceutical Company Limited (000756.SZ) is Hold, based on a StockRank of 62/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Shandong Xinhua Pharmaceutical Company Limited in?: Shandong Xinhua Pharmaceutical Company Limited (000756.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).